Ryan Walsh

NPI: 1144809765
Total Payments
$247.65
2024 Payments
$45.13
Companies
5
Transactions
12

Payment Breakdown by Category

Food & Beverage$247.65 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $247.65 12 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $70.86 4 $0 (2024)
Amgen Inc. $61.52 3 $0 (2022)
PFIZER INC. $54.55 2 $0 (2023)
Janssen Pharmaceuticals, Inc $37.29 2 $0 (2023)
Novartis Pharmaceuticals Corporation $23.43 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $45.13 2 Novartis Pharmaceuticals Corporation ($23.43)
2023 $95.48 5 AstraZeneca Pharmaceuticals LP ($49.16)
2022 $81.58 4 Amgen Inc. ($61.52)
2021 $25.46 1 PFIZER INC. ($25.46)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/07/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $23.43 General
Category: Cardiology/Vascular Diseases
03/22/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $21.70 General
Category: Respiratory
09/07/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $17.89 General
Category: Respiratory
08/22/2023 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $15.61 General
Category: Cardiovascular and Metabolism
08/17/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $17.23 General
Category: Cardiovascular & Metabolism
07/06/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $15.66 General
Category: Respiratory
06/29/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $29.09 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/13/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $20.06 General
Category: Cardiovascular & Metabolism
06/29/2022 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $26.52 General
Category: Cardiology
05/25/2022 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $17.94 General
Category: Cardiology
04/11/2022 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $17.06 General
Category: Cardiology
11/29/2021 PFIZER INC. ELIQUIS (Drug), VYNDAQEL Food and Beverage In-kind items and services $25.46 General
Category: CARDIOVASCULAR;METABOLIC DISEASE

About Ryan Walsh

Ryan Walsh is a General Practice healthcare provider based in Cambridge, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2021. The National Provider Identifier (NPI) number assigned to this provider is 1144809765.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ryan Walsh has received a total of $247.65 in payments from pharmaceutical and medical device companies, with $45.13 received in 2024. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($247.65).

Practice Information

  • Specialty General Practice
  • Location Cambridge, MA
  • Active Since 04/02/2021
  • Last Updated 07/12/2021
  • Taxonomy Code 208D00000X
  • Entity Type Individual
  • NPI Number 1144809765

Products in Payments

  • Repatha (Biological) $61.52
  • ELIQUIS (Drug) $54.55
  • XARELTO (Drug) $37.29
  • BREZTRI (Drug) $33.55
  • ENTRESTO (Drug) $23.43
  • AIRSUPRA (Drug) $21.70
  • LOKELMA (Drug) $15.61

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

General Practice Doctors in Cambridge